Aspire Biopharma Holdings Inc (NASDAQ:ASBP) price on Thursday, March 20, rose 4.29% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.69.
A look at the stock’s price movement, the close in the last trading session was $0.66, moving within a range at $0.6506 and $0.818. The beta value (5-Year monthly) was 0.366. Turning to its 52-week performance, $15.80 and $0.52 were the 52-week high and 52-week low respectively. Overall, ASBP moved -92.55% over the past month.
Aspire Biopharma Holdings Inc’s market cap currently stands at around $31.66 million, with investors looking forward to this quarter’s earnings report slated for in April.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ASBP is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
ASBP’s current price about -36.38% and -90.55% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 23.65, while 7-day volatility ratio is 15.04% and 31.45% in the 30-day chart. Further, Aspire Biopharma Holdings Inc (ASBP) has a beta value of 0.76, and an average true range (ATR) of 0.67.
If we refocus on Aspire Biopharma Holdings Inc (NASDAQ:ASBP), historical trading data shows that trading volumes averaged 1.94 over the past 10 days and 565.91K over the past 3 months. The company’s latest data on shares outstanding shows there are 46.01 million shares.
The 26.06% of Aspire Biopharma Holdings Inc’s shares are in the hands of company insiders while institutional holders own 1.01% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 47452.0 on 2025-02-28, giving us a short ratio of 0.09. Current price change has pushed the stock -94.02% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ASBP stock continues to rise going into the next quarter.
